Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
FY25 FACILITIES TASK ORDER A - REPLACE WOOD STREET STEAM & CONDENSATE PIPINGDepartment of Health and Human Services$3.0M obligationsEnds Sep 17, 2027
TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIESDepartment of Health and Human Services$4.8B obligationsEnds Sep 6, 2024
LONGITUDINAL STUDIES OF DOGS WITH CANCER AS A COMPARATIVE ONCOLOGY MODELDepartment of Health and Human Services$168.9K obligationsEnds Sep 8, 2026
DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATESDepartment of Health and Human Services$4.6M obligationsEnds Sep 14, 2030
126827 BUILDING 1023 ROOMS 8 AND 9 BSC REPLACEMENTDepartment of Health and Human Services$652.4K obligationsEnds Nov 15, 2027
FY25 FACILITIES TO G CONSTRUCTION OF BMP STRUCTURES FOR MDE STORM-WATER COMPLIANCEDepartment of Health and Human Services$2.7M obligationsEnds Sep 1, 2027
NIAID-VRC-MRNA VACCINE CAPABILITY ESTABLISHMENTDepartment of Health and Human Services$25.1M obligationsEnds Jun 17, 2030
THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM…Department of Health and Human Services$173.3M obligationsEnds May 31, 2029
MANUFACTURING CGMP GRADE HYDROXYCOBALAMINEDepartment of Health and Human Services$730.4K obligationsEnds Sep 14, 2030
NIAID RESEARCH DATA ECOSYSTEM FRAMEWORK (NIDEF)Department of Health and Human Services$19.7M obligationsEnds May 30, 2029
CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAINDepartment of Health and Human Services$2.4M obligationsEnds Sep 14, 2028
FY26 126816_B539 _B536 W END FIRE ALARMDepartment of Health and Human Services$1.8M obligationsEnds Dec 18, 2028
DATA SYSTEMS UPDATE, DATA INTEGRATION, AND COMPUTATIONAL APPLICATIONS TO SUPPORT DRUG DISCOVERY AND THERAPEUTICS DEVELOPMENTDepartment of Health and Human Services$8.4M obligationsEnds Mar 31, 2027
FY25 TO-C REFURBISH ELEVATORSDepartment of Health and Human Services$10.1M obligationsEnds Jan 27, 2027
NIAID DCR FY26-27 OPERATIONAL TASK ORDERDepartment of Health and Human Services$77.6M obligationsEnds Aug 30, 2026
INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TESTDepartment of Health and Human Services$1.0M obligationsEnds Jul 2, 2026
PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATEDepartment of Health and Human Services$1.1M obligationsEnds Mar 15, 2029
FY25 TO-BDepartment of Health and Human Services$2.0M obligationsEnds Sep 30, 2027
DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTSDepartment of Health and Human Services$6.6M obligationsEnds Sep 15, 2026
PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND…Department of Health and Human Services$63.1M obligationsEnds Aug 30, 2020
IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALSDepartment of Health and Human Services$14.8M obligationsEnds Sep 29, 2023
REFRACTORY CANCERS BIOSPECIMEN ACQUISITION AND GENOMIC CHARACTERIZATIONDepartment of Health and Human Services$4.3M obligationsEnds Mar 31, 2025
NCI OPERATIONAL TASK ORDERDepartment of Health and Human Services$1.8B obligationsEnds Sep 27, 2024
NIAID VRCDepartment of Health and Human Services$121.5M obligationsEnds Aug 30, 2024
IGF::OT::IGF HUMAN TUMOR ATLAS PILOT PROGRAMDepartment of Health and Human Services$13.4M obligationsEnds Jul 31, 2024